PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3653035-9 1987 These results suggest that cortisone, testosterone, and aldosterone decrease NGF levels in L cell-conditioned medium by reducing the cellular content of NGF mRNA. Testosterone 38-50 nerve growth factor Mus musculus 77-80 2224502-0 1990 Influences of neonatal and adult exposures to testosterone on the levels of the beta-subunit of nerve growth factor in the neural tissues of mice. Testosterone 46-58 nerve growth factor Mus musculus 80-115 2224502-2 1990 In this investigation, we examined the effects of castration of adult males, and of neonatal and/or adult treatments with testosterone on levels of beta-NGF in the several tissues of mice. Testosterone 122-134 nerve growth factor Mus musculus 148-156 2224502-4 1990 Continuous infusion of testosterone for one week into adult males that had been castrated at 2 months of age restored the level of beta-NGF in the three tissues mentioned above. Testosterone 23-35 nerve growth factor Mus musculus 131-139 2224502-6 1990 A one-week infusion of testosterone into adult females slightly increased levels of beta-NGF in the brain and spinal cord, but the same treatment of adult females given in advance a single dose of testosterone at 5 days of age caused a significant increase in its levels over those of untreated females. Testosterone 23-35 nerve growth factor Mus musculus 84-92 2224502-6 1990 A one-week infusion of testosterone into adult females slightly increased levels of beta-NGF in the brain and spinal cord, but the same treatment of adult females given in advance a single dose of testosterone at 5 days of age caused a significant increase in its levels over those of untreated females. Testosterone 197-209 nerve growth factor Mus musculus 84-92 2224502-7 1990 These results suggest that neonatal and adult exposures to testosterone can influence the endogenous concentration of beta-NGF in the brain and spinal cord. Testosterone 59-71 nerve growth factor Mus musculus 118-126 3377763-3 1988 Testosterone pretreatment, however, specifically augments the Mr 13,000 form of nerve growth factor in the salivary glands of female mice. Testosterone 0-12 nerve growth factor Mus musculus 80-99 3653035-0 1987 Cortisone, testosterone, and aldosterone reduce levels of nerve growth factor messenger ribonucleic acid in L-929 fibroblasts. Testosterone 11-23 nerve growth factor Mus musculus 58-77 3653035-9 1987 These results suggest that cortisone, testosterone, and aldosterone decrease NGF levels in L cell-conditioned medium by reducing the cellular content of NGF mRNA. Testosterone 38-50 nerve growth factor Mus musculus 153-156 3948788-1 1986 Thyroid hormone, testosterone, and glucocorticoids stimulate the production of nerve growth factor (NGF) in mouse submandibular glands, but little is known about the influences of these hormones on other sources of NGF. Testosterone 17-29 nerve growth factor Mus musculus 79-98 3948788-1 1986 Thyroid hormone, testosterone, and glucocorticoids stimulate the production of nerve growth factor (NGF) in mouse submandibular glands, but little is known about the influences of these hormones on other sources of NGF. Testosterone 17-29 nerve growth factor Mus musculus 100-103 7053993-7 1982 Testosterone significantly increased the NGF concentration in salivary glands, but the values in treated male mice were only one tenth those in the treated lean animals. Testosterone 0-12 nerve growth factor Mus musculus 41-44 3923174-5 1985 Testosterone administration before ligation resulted in decreased EGF and NGF levels of staining; however, staining of sections on the 1st and 3rd day was a little stronger than comparable stained sections of untreated mice. Testosterone 0-12 nerve growth factor Mus musculus 74-77 29724155-3 2019 Here, we conducted a 2-arm randomized clinical study and in vitro cell line experiments to investigate the effects of nerve growth factor (NGF) on serum testosterone and ED in diabetic males with sensorimotor polyneuropathy and to identify its underlying mechanisms. Testosterone 153-165 nerve growth factor Mus musculus 118-137 621204-6 1978 Castration reduced this value to one-third, while testosterone treatment of castrated animals restored the relative betaNGF synthesis to normal or more. Testosterone 50-62 nerve growth factor Mus musculus 116-123 14280173-0 1965 STUDIES OF THE NERVE GROWTH FACTOR IN SUBMANDIBULAR GLANDS OF FEMALE MICE TREATED WITH TESTOSTERONE. Testosterone 87-99 nerve growth factor Mus musculus 15-34 29724155-3 2019 Here, we conducted a 2-arm randomized clinical study and in vitro cell line experiments to investigate the effects of nerve growth factor (NGF) on serum testosterone and ED in diabetic males with sensorimotor polyneuropathy and to identify its underlying mechanisms. Testosterone 153-165 nerve growth factor Mus musculus 139-142 29724155-6 2019 Thus, NGF treatment effectively improves type 2 diabetes-induced hypotestosterone and ED outcome through a mechanism that includes upregulation of key enzymes in testosterone biosynthesis. Testosterone 69-81 nerve growth factor Mus musculus 6-9 21646391-9 2011 These results indicate that an excess of NGF in the ovary promotes steroidogenesis by enhancing the expression of enzyme genes involved in 17-OHP(4), testosterone, and E(2) synthesis, and causes GC apoptosis by activating a TNF/ STMN1-mediated cell death pathway. Testosterone 150-162 nerve growth factor Mus musculus 41-44 27208621-8 2016 EA in testosterone exposed dams compared with controls increased systolic pressure by 30%, decreased circulating norepinephrine and corticosterone, fetal and placental weight and placental VEGFR1 and proNGF protein expression, and increased the VEGFA/VEGFR1 ratio, mature NGF (mNGF) and the mNGF/proNGF ratio. Testosterone 6-18 nerve growth factor Mus musculus 203-206 27208621-8 2016 EA in testosterone exposed dams compared with controls increased systolic pressure by 30%, decreased circulating norepinephrine and corticosterone, fetal and placental weight and placental VEGFR1 and proNGF protein expression, and increased the VEGFA/VEGFR1 ratio, mature NGF (mNGF) and the mNGF/proNGF ratio. Testosterone 6-18 nerve growth factor Mus musculus 277-281 27208621-8 2016 EA in testosterone exposed dams compared with controls increased systolic pressure by 30%, decreased circulating norepinephrine and corticosterone, fetal and placental weight and placental VEGFR1 and proNGF protein expression, and increased the VEGFA/VEGFR1 ratio, mature NGF (mNGF) and the mNGF/proNGF ratio. Testosterone 6-18 nerve growth factor Mus musculus 291-295